LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LNSR is expected to report earnings to fall 96.77% to -7 cents per share on August 06
Q2'25
Est.
$-0.08
Q1'25
Missed
by $2.16
Q4'24
Missed
by $1.43
Q3'24
Beat
by $0.16
Q2'24
Missed
by $0.49
The last earnings report on May 08 showed earnings per share of -231 cents, missing the estimate of -15 cents. With 26.98K shares outstanding, the current market capitalization sits at 38.71M.